PMC:7144273 / 44028-44521 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T393","span":{"begin":133,"end":155},"obj":"Body_part"},{"id":"T394","span":{"begin":150,"end":155},"obj":"Body_part"},{"id":"T395","span":{"begin":252,"end":256},"obj":"Body_part"},{"id":"T396","span":{"begin":280,"end":285},"obj":"Body_part"},{"id":"T397","span":{"begin":300,"end":304},"obj":"Body_part"},{"id":"T398","span":{"begin":328,"end":333},"obj":"Body_part"},{"id":"T399","span":{"begin":410,"end":415},"obj":"Body_part"}],"attributes":[{"id":"A393","pred":"fma_id","subj":"T393","obj":"http://purl.org/sig/ont/fma/fma0326143"},{"id":"A394","pred":"fma_id","subj":"T394","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A395","pred":"fma_id","subj":"T395","obj":"http://purl.org/sig/ont/fma/fma256135"},{"id":"A396","pred":"fma_id","subj":"T396","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A397","pred":"fma_id","subj":"T397","obj":"http://purl.org/sig/ont/fma/fma256135"},{"id":"A398","pred":"fma_id","subj":"T398","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A399","pred":"fma_id","subj":"T399","obj":"http://purl.org/sig/ont/fma/fma63083"}],"text":"16 28-02-2020; 28-02-2020 to 31-12-2021 1–2Not recruiting NCT04288102;https://clinicaltrials.gov/ct2/show/NCT04288102 Treatment with mesenchymal stem cells for severe corona virus disease 2019 (COVID-19) MSCs 45 Experimental group: 3 times of MSCs; if body weight ≥70 kg, 4.0×107 cells each time; if body weight \u003c70 kg, 3.0×107 cells each time; i.v. at days 0, 3 and 6Control group: saline containing 1% human serum albumin (solution used for MSCs), 3 times of placebo, i.v. at days 0, 3 and 6"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T140","span":{"begin":410,"end":415},"obj":"Body_part"}],"attributes":[{"id":"A140","pred":"uberon_id","subj":"T140","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"}],"text":"16 28-02-2020; 28-02-2020 to 31-12-2021 1–2Not recruiting NCT04288102;https://clinicaltrials.gov/ct2/show/NCT04288102 Treatment with mesenchymal stem cells for severe corona virus disease 2019 (COVID-19) MSCs 45 Experimental group: 3 times of MSCs; if body weight ≥70 kg, 4.0×107 cells each time; if body weight \u003c70 kg, 3.0×107 cells each time; i.v. at days 0, 3 and 6Control group: saline containing 1% human serum albumin (solution used for MSCs), 3 times of placebo, i.v. at days 0, 3 and 6"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T296","span":{"begin":167,"end":192},"obj":"Disease"},{"id":"T297","span":{"begin":194,"end":202},"obj":"Disease"}],"attributes":[{"id":"A296","pred":"mondo_id","subj":"T296","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A297","pred":"mondo_id","subj":"T297","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"16 28-02-2020; 28-02-2020 to 31-12-2021 1–2Not recruiting NCT04288102;https://clinicaltrials.gov/ct2/show/NCT04288102 Treatment with mesenchymal stem cells for severe corona virus disease 2019 (COVID-19) MSCs 45 Experimental group: 3 times of MSCs; if body weight ≥70 kg, 4.0×107 cells each time; if body weight \u003c70 kg, 3.0×107 cells each time; i.v. at days 0, 3 and 6Control group: saline containing 1% human serum albumin (solution used for MSCs), 3 times of placebo, i.v. at days 0, 3 and 6"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T611","span":{"begin":133,"end":155},"obj":"http://purl.obolibrary.org/obo/CL_0000134"},{"id":"T612","span":{"begin":174,"end":179},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T613","span":{"begin":209,"end":211},"obj":"http://purl.obolibrary.org/obo/CLO_0053799"},{"id":"T614","span":{"begin":280,"end":285},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T615","span":{"begin":328,"end":333},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T616","span":{"begin":404,"end":409},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"}],"text":"16 28-02-2020; 28-02-2020 to 31-12-2021 1–2Not recruiting NCT04288102;https://clinicaltrials.gov/ct2/show/NCT04288102 Treatment with mesenchymal stem cells for severe corona virus disease 2019 (COVID-19) MSCs 45 Experimental group: 3 times of MSCs; if body weight ≥70 kg, 4.0×107 cells each time; if body weight \u003c70 kg, 3.0×107 cells each time; i.v. at days 0, 3 and 6Control group: saline containing 1% human serum albumin (solution used for MSCs), 3 times of placebo, i.v. at days 0, 3 and 6"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T217","span":{"begin":167,"end":173},"obj":"Chemical"},{"id":"T218","span":{"begin":225,"end":230},"obj":"Chemical"},{"id":"T219","span":{"begin":376,"end":381},"obj":"Chemical"},{"id":"T220","span":{"begin":425,"end":433},"obj":"Chemical"}],"attributes":[{"id":"A217","pred":"chebi_id","subj":"T217","obj":"http://purl.obolibrary.org/obo/CHEBI_37409"},{"id":"A218","pred":"chebi_id","subj":"T218","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A219","pred":"chebi_id","subj":"T219","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A220","pred":"chebi_id","subj":"T220","obj":"http://purl.obolibrary.org/obo/CHEBI_75958"}],"text":"16 28-02-2020; 28-02-2020 to 31-12-2021 1–2Not recruiting NCT04288102;https://clinicaltrials.gov/ct2/show/NCT04288102 Treatment with mesenchymal stem cells for severe corona virus disease 2019 (COVID-19) MSCs 45 Experimental group: 3 times of MSCs; if body weight ≥70 kg, 4.0×107 cells each time; if body weight \u003c70 kg, 3.0×107 cells each time; i.v. at days 0, 3 and 6Control group: saline containing 1% human serum albumin (solution used for MSCs), 3 times of placebo, i.v. at days 0, 3 and 6"}

{"project":"LitCovid-sentences","denotations":[{"id":"T197","span":{"begin":0,"end":231},"obj":"Sentence"},{"id":"T198","span":{"begin":232,"end":493},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"16 28-02-2020; 28-02-2020 to 31-12-2021 1–2Not recruiting NCT04288102;https://clinicaltrials.gov/ct2/show/NCT04288102 Treatment with mesenchymal stem cells for severe corona virus disease 2019 (COVID-19) MSCs 45 Experimental group: 3 times of MSCs; if body weight ≥70 kg, 4.0×107 cells each time; if body weight \u003c70 kg, 3.0×107 cells each time; i.v. at days 0, 3 and 6Control group: saline containing 1% human serum albumin (solution used for MSCs), 3 times of placebo, i.v. at days 0, 3 and 6"}